Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lantheus Holdings, Inc. - Common Stock
(NQ:
LNTH
)
55.60
-0.76 (-1.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lantheus Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Why Is Lantheus Stock Trading Lower On Wednesday?
July 16, 2025
CMS proposes a $140 drug packaging threshold and a $655 diagnostic radiopharmaceutical threshold for CY 2026, using inflation-adjusted PPI data.
Via
Benzinga
Why Lantheus (LNTH) Stock Is Down Today
July 16, 2025
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 7.7% in the morning session after the stock hit a new 52-week low amid persistent investor concerns over rising competition...
Via
StockStory
Topics
ETFs
Stocks
World Trade
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know
July 11, 2025
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.
Via
StockStory
Topics
ETFs
Stocks
World Trade
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) – An Undervalued Stock with Strong Fundamentals
July 05, 2025
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is an undervalued healthcare stock with strong profitability, financial health, and reasonable growth potential, making it a candidate for value investors.
Via
Chartmill
What Does the Market Think About Lantheus Holdings?
July 04, 2025
Via
Benzinga
What Does the Market Think About Lantheus Holdings?
June 05, 2025
Via
Benzinga
Earnings Scheduled For May 7, 2025
May 07, 2025
Via
Benzinga
Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q1
June 23, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Lantheus (NASDAQ:LNTH) and the best and...
Via
StockStory
Topics
Artificial Intelligence
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations
June 23, 2025
Via
Stocktwits
Topics
Cannabis
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) – An Undervalued Stock With Strong Fundamentals
June 14, 2025
Lantheus Holdings (NASDAQ:LNTH) presents an undervalued opportunity with strong profitability, financial health, and reasonable growth, making it a candidate for value investors.
Via
Chartmill
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
June 11, 2025
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus to Present at the 2025 Truist Securities MedTech Conference
June 10, 2025
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
June 03, 2025
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus Holdings Inc (NASDAQ:LNTH) – An Undervalued Stock with Strong Fundamentals
May 23, 2025
Lantheus Holdings (LNTH) is an undervalued stock with strong profitability, financial health, and growth potential, trading below industry averages. A solid pick for value investors.
Via
Chartmill
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
May 14, 2025
These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and next
Via
MarketBeat
Topics
Earnings
LNTH Q1 Earnings Call: Lantheus Lowers Outlook Amid Product Shifts and Divestitures
May 09, 2025
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $372.8 million. The company’s full-year revenue...
Via
StockStory
Lantheus Holdings, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH
May 07, 2025
From
DJS Law Group
Via
Business Wire
Why Lantheus (LNTH) Shares Are Getting Obliterated Today
May 07, 2025
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 22.2% in the afternoon session after the company reported weak first quarter 2025 results which included a significant miss on...
Via
StockStory
Topics
Artificial Intelligence
Sarepta Therapeutics, Mercury Systems, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
May 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 07, 2025
Via
Benzinga
Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops
May 07, 2025
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $372.8 million. The company’s full-year revenue...
Via
StockStory
Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update
May 07, 2025
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus Announces Sale of SPECT Business to SHINE Technologies
May 06, 2025
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Lantheus Earnings: What To Look For From LNTH
May 06, 2025
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be announcing earnings results tomorrow before market open. Here’s what you need to know.
Via
StockStory
8 Health Care Stocks Whale Activity In Today's Session
May 01, 2025
Via
Benzinga
Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies
April 30, 2025
Company plans to file NDA in the third quarter of this year
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
In the world of growth stocks, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) shines as a value proposition.
April 29, 2025
LANTHEUS HOLDINGS INC could be undervalued. NASDAQ:LNTH is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced.
Via
Chartmill
Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time
April 23, 2025
From
Lantheus Holdings, Inc.
Via
GlobeNewswire
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
April 10, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - imaging, diagnostics stocks...
Via
StockStory
Topics
Artificial Intelligence
LANTHEUS HOLDINGS INC (NASDAQ:LNTH), a growth stock which is not overvalued.
April 07, 2025
Discover LANTHEUS HOLDINGS INC, an undervalued growth gem. NASDAQ:LNTH is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing...
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.